NeuMoDx coronavirus test gets emergency authorization

LabPulse.com staff writers
Mar 31, 2020
2019 05 02 23 38 2538 Check Mark 400

NeuMoDx Molecular's assay for SARS-CoV-2 has received an emergency use authorization (EUA) from the U.S. Food and Drug Administration.

The reverse transcription polymerase chain reaction (RT-PCR) test was designed for use on the company's high-throughput NeuMoDx 288 and 96 molecular systems in CLIA-certified hospitals and labs that perform high-complexity testing. Results are available in as little as 80 minutes, according to the company.

NeuMoDx also noted that reagents and consumables associated with the SARS-CoV-2 test are ready to use and do not require refrigeration.

Latest in PCR
Business Regulation Graphic Social Resized
Eurobio Scientific obtains IVDR CE markings for PCR tests
May 24, 2023
Artificial Intelligence Ai Social
A. Menarini launches full automated MDx platform at WorldLab-EuroMedLab
May 23, 2023
Visit our Molecular Diagnostics Community
Sponsored
Visit our Molecular Diagnostics Community
May 11, 2023
Business Financial Results Social
Bio-Rad Laboratories Q1 net sales drop 3%; firm lowers full-year guidance
May 5, 2023
Related Stories
2020 02 25 17 48 0053 Thumbs Up New 400
PCR
Ipsum gets FDA nod for COVID-19 test
2020 03 20 23 29 9036 Virus Coronavirus Microscope 400
Health Topics
BioIQ readies COVID-19 saliva test
2020 01 21 22 13 2411 Virus Coronavirus 400
Immunoassays
BodySphere's 2-minute antibody test for COVID-19 gets green light in U.S.
Visit our Molecular Diagnostics Community
Sponsor Content
Visit our Molecular Diagnostics Community
More in PCR
Eurobio Scientific obtains IVDR CE markings for PCR tests
The CE markings enable the firm to market three of its PCR tests as class C in vitro diagnostic medical devices for the detection of infectious diseases.
May 24, 2023
Business Regulation Graphic Social Resized
A. Menarini launches full automated MDx platform at WorldLab-EuroMedLab
The system, Prime MDx, is an all-in-one, sample-to-result platform designed to allows users to process a variety of sample types through real-time polymerase chain reaction (PCR), the Florence, Italy-based firm said.
May 23, 2023
Artificial Intelligence Ai Social
BioMérieux receives FDA CLIA waiver for multiplex PCR respiratory panel
In about 15 minutes, the panel detects five of the most common viral causes of upper respiratory tract infections: SARS-CoV-2, influenza A, influenza B, respiratory syncytial virus (RSV), and rhinovirus.
May 11, 2023
Patient Doctor Women Social
Bio-Rad Laboratories Q1 net sales drop 3%; firm lowers full-year guidance
Bio-Rad shares were down on Friday, a day after the firm updated its financial outlook for full-year 2023; it anticipates non-GAAP currency-neutral revenue growth of approximately 4.5% compared to its previous estimate of 6% to 7%.
May 5, 2023
Business Financial Results Social
Qiagen launching syndromic molecular diagnostic system with respiratory panel in Japan
Qiagen said Monday that its QIAstat-Dx syndromic testing system is expected to be available soon in Japan with a SARS-CoV-2 Respiratory Panel that can detect more than 20 pathogens from a patient sample.
April 24, 2023
Women Laboratory Social
Curative spins off Sensible Diagnostics to commercialize point-of-care PCR platform
The spin-off is utilizing the experience Curative has gained with its diagnostics business during the pandemic, having run more than two million molecular point-of-care COVID-19 tests.
April 24, 2023
Blood Test Samples Lab Social
Seegene collaborates with Hy Laboratories, seeks similar deals to broaden syndromic testing
Embracing an open innovation model, the company is seeking leading companies to join a collaborative network and collectively develop hundreds, or more, of syndromic PCR assays annually to serve both local and global markets.
March 28, 2023
Covid 19 Global Financial Crisis Social
Long COVID less likely after Omicron than after original virus, Swiss researchers find
In a Swiss study, investigators have found that long COVID is less likely after Omicron infection than after infection by the original wild-type SARS-CoV-2 virus.
March 9, 2023
Covid Treatment Doctor Social
Servier, Qiagen partner to develop companion diagnostic test for AML
Under a master collaboration agreement, Qiagen will develop and validate a real-time PCR-based in vitro diagnostic test that can be used to detect IDH1 gene mutations in whole blood and bone marrow aspirates in AML.
March 9, 2023
Leukemia Aml Social
Virufy nabs BARDA contract to develop cough- and speech-based COVID-19 detection technology
The project supports the firm’s aim to research and develop COVID-19 screening tools using artificial intelligence (AI)/machine learning (ML) technology.
March 8, 2023
Covid 19 Spread Usa Social
Bio-Rad Laboratories revenue growth flat in Q4
Revenue increased almost 11% on a currency-neutral basis when COVID-related sales comparisons were excluded.
February 17, 2023
Business Financial Results Social
LumiraDx obtains FDA authorization for test to detect flu A, flu B, SARS-CoV-2
The test leverages a single-step direct method for nucleic acid extraction and amplification on validated open RT-PCR instruments.
February 7, 2023
Covid 19 Antibody Social
Page 1 of 22
Next Page